nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—LRRK2—Alzheimer's disease	0.551	1	CbGaD
Ruxolitinib—Haemorrhage intracranial—Donepezil—Alzheimer's disease	0.00426	0.0396	CcSEcCtD
Ruxolitinib—Haemorrhage intracranial—Memantine—Alzheimer's disease	0.00387	0.0359	CcSEcCtD
Ruxolitinib—Haemorrhage intracranial—Rivastigmine—Alzheimer's disease	0.00378	0.0352	CcSEcCtD
Ruxolitinib—Night sweats—Donepezil—Alzheimer's disease	0.00324	0.0301	CcSEcCtD
Ruxolitinib—Bone pain—Galantamine—Alzheimer's disease	0.00235	0.0219	CcSEcCtD
Ruxolitinib—Herpes zoster—Donepezil—Alzheimer's disease	0.00232	0.0216	CcSEcCtD
Ruxolitinib—ANKK1—telencephalon—Alzheimer's disease	0.00219	0.0172	CbGeAlD
Ruxolitinib—Herpes zoster—Memantine—Alzheimer's disease	0.00211	0.0196	CcSEcCtD
Ruxolitinib—Herpes zoster—Rivastigmine—Alzheimer's disease	0.00206	0.0192	CcSEcCtD
Ruxolitinib—RPS6KA6—embryo—Alzheimer's disease	0.002	0.0157	CbGeAlD
Ruxolitinib—Contusion—Donepezil—Alzheimer's disease	0.002	0.0186	CcSEcCtD
Ruxolitinib—GRK1—forebrain—Alzheimer's disease	0.00189	0.0148	CbGeAlD
Ruxolitinib—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00185	0.0172	CcSEcCtD
Ruxolitinib—PRKCE—forebrain—Alzheimer's disease	0.00185	0.0145	CbGeAlD
Ruxolitinib—BMPR2—blood vessel—Alzheimer's disease	0.0018	0.0141	CbGeAlD
Ruxolitinib—GRK1—telencephalon—Alzheimer's disease	0.00173	0.0136	CbGeAlD
Ruxolitinib—PRKCE—telencephalon—Alzheimer's disease	0.0017	0.0133	CbGeAlD
Ruxolitinib—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.00168	0.0156	CcSEcCtD
Ruxolitinib—PLK3—embryo—Alzheimer's disease	0.00167	0.0131	CbGeAlD
Ruxolitinib—Bone pain—Memantine—Alzheimer's disease	0.00166	0.0154	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00164	0.0153	CcSEcCtD
Ruxolitinib—Bone pain—Rivastigmine—Alzheimer's disease	0.00162	0.0151	CcSEcCtD
Ruxolitinib—CAMK1—forebrain—Alzheimer's disease	0.00138	0.0108	CbGeAlD
Ruxolitinib—MARK2—forebrain—Alzheimer's disease	0.00134	0.0105	CbGeAlD
Ruxolitinib—ANKK1—nervous system—Alzheimer's disease	0.00129	0.0101	CbGeAlD
Ruxolitinib—JAK2—blood vessel—Alzheimer's disease	0.00129	0.0101	CbGeAlD
Ruxolitinib—JAK1—embryo—Alzheimer's disease	0.00128	0.0101	CbGeAlD
Ruxolitinib—DCLK1—embryo—Alzheimer's disease	0.00128	0.0101	CbGeAlD
Ruxolitinib—Weight decreased—Galantamine—Alzheimer's disease	0.00128	0.0119	CcSEcCtD
Ruxolitinib—CAMK1—telencephalon—Alzheimer's disease	0.00127	0.00997	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00127	0.0118	CcSEcCtD
Ruxolitinib—Urinary tract infection—Galantamine—Alzheimer's disease	0.00123	0.0114	CcSEcCtD
Ruxolitinib—Haematuria—Galantamine—Alzheimer's disease	0.0012	0.0112	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00119	0.0111	CcSEcCtD
Ruxolitinib—Epistaxis—Galantamine—Alzheimer's disease	0.00119	0.0111	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00115	0.0107	CcSEcCtD
Ruxolitinib—Haemoglobin—Galantamine—Alzheimer's disease	0.00114	0.0106	CcSEcCtD
Ruxolitinib—JAK1—forebrain—Alzheimer's disease	0.00114	0.00889	CbGeAlD
Ruxolitinib—DCLK1—forebrain—Alzheimer's disease	0.00114	0.00889	CbGeAlD
Ruxolitinib—Haemorrhage—Galantamine—Alzheimer's disease	0.00113	0.0105	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00113	0.0105	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00112	0.0104	CcSEcCtD
Ruxolitinib—CAMK1D—forebrain—Alzheimer's disease	0.00111	0.00868	CbGeAlD
Ruxolitinib—ROCK1—embryo—Alzheimer's disease	0.00111	0.00866	CbGeAlD
Ruxolitinib—PRKG2—nervous system—Alzheimer's disease	0.00107	0.00841	CbGeAlD
Ruxolitinib—HIPK2—forebrain—Alzheimer's disease	0.00106	0.0083	CbGeAlD
Ruxolitinib—JAK1—telencephalon—Alzheimer's disease	0.00104	0.00818	CbGeAlD
Ruxolitinib—DCLK1—telencephalon—Alzheimer's disease	0.00104	0.00818	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—Alzheimer's disease	0.00103	0.00809	CbGeAlD
Ruxolitinib—GRK1—nervous system—Alzheimer's disease	0.00102	0.00802	CbGeAlD
Ruxolitinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00102	0.00944	CcSEcCtD
Ruxolitinib—PRKCE—nervous system—Alzheimer's disease	0.001	0.00785	CbGeAlD
Ruxolitinib—Weight increased—Donepezil—Alzheimer's disease	0.000998	0.00927	CcSEcCtD
Ruxolitinib—DAPK2—telencephalon—Alzheimer's disease	0.000996	0.0078	CbGeAlD
Ruxolitinib—Weight decreased—Donepezil—Alzheimer's disease	0.000992	0.00922	CcSEcCtD
Ruxolitinib—Malnutrition—Galantamine—Alzheimer's disease	0.000986	0.00916	CcSEcCtD
Ruxolitinib—GRK1—central nervous system—Alzheimer's disease	0.000985	0.00772	CbGeAlD
Ruxolitinib—ROCK1—forebrain—Alzheimer's disease	0.000978	0.00766	CbGeAlD
Ruxolitinib—Infestation—Donepezil—Alzheimer's disease	0.000977	0.00908	CcSEcCtD
Ruxolitinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000977	0.00908	CcSEcCtD
Ruxolitinib—HIPK2—telencephalon—Alzheimer's disease	0.000974	0.00764	CbGeAlD
Ruxolitinib—Flatulence—Galantamine—Alzheimer's disease	0.000971	0.00903	CcSEcCtD
Ruxolitinib—PRKCE—central nervous system—Alzheimer's disease	0.000964	0.00756	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—Alzheimer's disease	0.000962	0.00754	CbGeAlD
Ruxolitinib—PLK1—nervous system—Alzheimer's disease	0.000962	0.00754	CbGeAlD
Ruxolitinib—MAST1—nervous system—Alzheimer's disease	0.000962	0.00754	CbGeAlD
Ruxolitinib—DYRK1A—forebrain—Alzheimer's disease	0.000953	0.00747	CbGeAlD
Ruxolitinib—Urinary tract infection—Donepezil—Alzheimer's disease	0.00095	0.00883	CcSEcCtD
Ruxolitinib—BMPR2—forebrain—Alzheimer's disease	0.00095	0.00744	CbGeAlD
Ruxolitinib—Pancytopenia—Memantine—Alzheimer's disease	0.000945	0.00879	CcSEcCtD
Ruxolitinib—PRKCE—cerebellum—Alzheimer's disease	0.000943	0.00739	CbGeAlD
Ruxolitinib—DAPK3—telencephalon—Alzheimer's disease	0.000936	0.00734	CbGeAlD
Ruxolitinib—Haematuria—Donepezil—Alzheimer's disease	0.000932	0.00866	CcSEcCtD
Ruxolitinib—Neutropenia—Memantine—Alzheimer's disease	0.000931	0.00865	CcSEcCtD
Ruxolitinib—PLK1—central nervous system—Alzheimer's disease	0.000927	0.00726	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—Alzheimer's disease	0.000927	0.00726	CbGeAlD
Ruxolitinib—MAST1—central nervous system—Alzheimer's disease	0.000927	0.00726	CbGeAlD
Ruxolitinib—Epistaxis—Donepezil—Alzheimer's disease	0.000922	0.00857	CcSEcCtD
Ruxolitinib—DCLK3—nervous system—Alzheimer's disease	0.000912	0.00715	CbGeAlD
Ruxolitinib—Anaemia—Galantamine—Alzheimer's disease	0.000911	0.00847	CcSEcCtD
Ruxolitinib—Weight increased—Memantine—Alzheimer's disease	0.000906	0.00842	CcSEcCtD
Ruxolitinib—RPS6KA6—cerebellum—Alzheimer's disease	0.000906	0.0071	CbGeAlD
Ruxolitinib—MAST1—cerebellum—Alzheimer's disease	0.000906	0.0071	CbGeAlD
Ruxolitinib—Weight decreased—Memantine—Alzheimer's disease	0.0009	0.00837	CcSEcCtD
Ruxolitinib—ROCK1—telencephalon—Alzheimer's disease	0.000899	0.00704	CbGeAlD
Ruxolitinib—Infestation—Memantine—Alzheimer's disease	0.000887	0.00825	CcSEcCtD
Ruxolitinib—Infestation NOS—Memantine—Alzheimer's disease	0.000887	0.00825	CcSEcCtD
Ruxolitinib—Weight increased—Rivastigmine—Alzheimer's disease	0.000886	0.00824	CcSEcCtD
Ruxolitinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000882	0.0082	CcSEcCtD
Ruxolitinib—Weight decreased—Rivastigmine—Alzheimer's disease	0.000881	0.00819	CcSEcCtD
Ruxolitinib—DCLK3—central nervous system—Alzheimer's disease	0.000878	0.00688	CbGeAlD
Ruxolitinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000877	0.00815	CcSEcCtD
Ruxolitinib—DYRK1A—telencephalon—Alzheimer's disease	0.000877	0.00687	CbGeAlD
Ruxolitinib—BMPR2—telencephalon—Alzheimer's disease	0.000873	0.00684	CbGeAlD
Ruxolitinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000868	0.00807	CcSEcCtD
Ruxolitinib—Infestation—Rivastigmine—Alzheimer's disease	0.000868	0.00807	CcSEcCtD
Ruxolitinib—Urinary tract infection—Memantine—Alzheimer's disease	0.000863	0.00802	CcSEcCtD
Ruxolitinib—BMP2K—forebrain—Alzheimer's disease	0.00085	0.00666	CbGeAlD
Ruxolitinib—CAMK2G—forebrain—Alzheimer's disease	0.00085	0.00666	CbGeAlD
Ruxolitinib—Haematuria—Memantine—Alzheimer's disease	0.000846	0.00786	CcSEcCtD
Ruxolitinib—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000844	0.00784	CcSEcCtD
Ruxolitinib—LRRK2—forebrain—Alzheimer's disease	0.000842	0.0066	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000839	0.0078	CcSEcCtD
Ruxolitinib—Epistaxis—Memantine—Alzheimer's disease	0.000837	0.00778	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000833	0.00774	CcSEcCtD
Ruxolitinib—Haematuria—Rivastigmine—Alzheimer's disease	0.000828	0.00769	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000821	0.00763	CcSEcCtD
Ruxolitinib—PRKG2—brain—Alzheimer's disease	0.00082	0.00643	CbGeAlD
Ruxolitinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000819	0.00761	CcSEcCtD
Ruxolitinib—RET—embryo—Alzheimer's disease	0.000817	0.0064	CbGeAlD
Ruxolitinib—PLK3—nervous system—Alzheimer's disease	0.000803	0.00629	CbGeAlD
Ruxolitinib—Haemoglobin—Memantine—Alzheimer's disease	0.000801	0.00744	CcSEcCtD
Ruxolitinib—Haemorrhage—Memantine—Alzheimer's disease	0.000797	0.0074	CcSEcCtD
Ruxolitinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000789	0.00733	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000787	0.00732	CcSEcCtD
Ruxolitinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000783	0.00728	CcSEcCtD
Ruxolitinib—GRK1—brain—Alzheimer's disease	0.000782	0.00613	CbGeAlD
Ruxolitinib—CAMK2G—telencephalon—Alzheimer's disease	0.000781	0.00612	CbGeAlD
Ruxolitinib—Skin disorder—Galantamine—Alzheimer's disease	0.000781	0.00726	CcSEcCtD
Ruxolitinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000779	0.00724	CcSEcCtD
Ruxolitinib—LRRK2—telencephalon—Alzheimer's disease	0.000774	0.00607	CbGeAlD
Ruxolitinib—PLK3—central nervous system—Alzheimer's disease	0.000773	0.00606	CbGeAlD
Ruxolitinib—JAK2—embryo—Alzheimer's disease	0.000772	0.00605	CbGeAlD
Ruxolitinib—PRKCE—brain—Alzheimer's disease	0.000766	0.006	CbGeAlD
Ruxolitinib—Malnutrition—Donepezil—Alzheimer's disease	0.000764	0.0071	CcSEcCtD
Ruxolitinib—Flatulence—Donepezil—Alzheimer's disease	0.000753	0.007	CcSEcCtD
Ruxolitinib—CAMK1—nervous system—Alzheimer's disease	0.000751	0.00589	CbGeAlD
Ruxolitinib—PLK1—brain—Alzheimer's disease	0.000736	0.00576	CbGeAlD
Ruxolitinib—RPS6KA6—brain—Alzheimer's disease	0.000736	0.00576	CbGeAlD
Ruxolitinib—MAST1—brain—Alzheimer's disease	0.000736	0.00576	CbGeAlD
Ruxolitinib—MARK2—nervous system—Alzheimer's disease	0.000729	0.00571	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—Alzheimer's disease	0.000723	0.00567	CbGeAlD
Ruxolitinib—MAP3K2—telencephalon—Alzheimer's disease	0.00071	0.00556	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—Alzheimer's disease	0.000707	0.00554	CbGeAlD
Ruxolitinib—Anaemia—Donepezil—Alzheimer's disease	0.000706	0.00656	CcSEcCtD
Ruxolitinib—MAP3K7—telencephalon—Alzheimer's disease	0.000703	0.00551	CbGeAlD
Ruxolitinib—MARK2—central nervous system—Alzheimer's disease	0.000702	0.0055	CbGeAlD
Ruxolitinib—DCLK3—brain—Alzheimer's disease	0.000697	0.00546	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000694	0.00645	CcSEcCtD
Ruxolitinib—Malnutrition—Memantine—Alzheimer's disease	0.000693	0.00645	CcSEcCtD
Ruxolitinib—Fatigue—Galantamine—Alzheimer's disease	0.000693	0.00645	CcSEcCtD
Ruxolitinib—TYK2—telencephalon—Alzheimer's disease	0.00069	0.00541	CbGeAlD
Ruxolitinib—MARK2—cerebellum—Alzheimer's disease	0.000686	0.00538	CbGeAlD
Ruxolitinib—Flatulence—Memantine—Alzheimer's disease	0.000683	0.00635	CcSEcCtD
Ruxolitinib—JAK2—forebrain—Alzheimer's disease	0.000683	0.00535	CbGeAlD
Ruxolitinib—MKNK2—telencephalon—Alzheimer's disease	0.000681	0.00534	CbGeAlD
Ruxolitinib—IRAK1—telencephalon—Alzheimer's disease	0.000681	0.00534	CbGeAlD
Ruxolitinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000678	0.00631	CcSEcCtD
Ruxolitinib—Flatulence—Rivastigmine—Alzheimer's disease	0.000668	0.00621	CcSEcCtD
Ruxolitinib—Anaemia—Memantine—Alzheimer's disease	0.000641	0.00596	CcSEcCtD
Ruxolitinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000636	0.00591	CcSEcCtD
Ruxolitinib—TAOK2—cerebellum—Alzheimer's disease	0.000635	0.00498	CbGeAlD
Ruxolitinib—JAK2—telencephalon—Alzheimer's disease	0.000628	0.00492	CbGeAlD
Ruxolitinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000627	0.00583	CcSEcCtD
Ruxolitinib—JAK3—nervous system—Alzheimer's disease	0.00062	0.00486	CbGeAlD
Ruxolitinib—Infection—Donepezil—Alzheimer's disease	0.000619	0.00576	CcSEcCtD
Ruxolitinib—DCLK1—nervous system—Alzheimer's disease	0.000616	0.00483	CbGeAlD
Ruxolitinib—JAK1—nervous system—Alzheimer's disease	0.000616	0.00483	CbGeAlD
Ruxolitinib—PLK3—brain—Alzheimer's disease	0.000614	0.00481	CbGeAlD
Ruxolitinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000611	0.00568	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00061	0.00567	CcSEcCtD
Ruxolitinib—CAMK1D—nervous system—Alzheimer's disease	0.000601	0.00471	CbGeAlD
Ruxolitinib—TAOK3—forebrain—Alzheimer's disease	0.0006	0.0047	CbGeAlD
Ruxolitinib—PHKG2—nervous system—Alzheimer's disease	0.000598	0.00469	CbGeAlD
Ruxolitinib—JAK3—central nervous system—Alzheimer's disease	0.000597	0.00468	CbGeAlD
Ruxolitinib—JAK1—central nervous system—Alzheimer's disease	0.000593	0.00465	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—Alzheimer's disease	0.000593	0.00465	CbGeAlD
Ruxolitinib—LTK—brain—Alzheimer's disease	0.000593	0.00465	CbGeAlD
Ruxolitinib—JAK3—cerebellum—Alzheimer's disease	0.000584	0.00457	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—Alzheimer's disease	0.00058	0.00454	CbGeAlD
Ruxolitinib—JAK1—cerebellum—Alzheimer's disease	0.00058	0.00454	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—Alzheimer's disease	0.000579	0.00454	CbGeAlD
Ruxolitinib—STK16—nervous system—Alzheimer's disease	0.000578	0.00453	CbGeAlD
Ruxolitinib—Asthenia—Galantamine—Alzheimer's disease	0.000577	0.00536	CcSEcCtD
Ruxolitinib—PHKG2—central nervous system—Alzheimer's disease	0.000576	0.00451	CbGeAlD
Ruxolitinib—HIPK2—nervous system—Alzheimer's disease	0.000575	0.00451	CbGeAlD
Ruxolitinib—CAMK1—brain—Alzheimer's disease	0.000574	0.0045	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000574	0.00533	CcSEcCtD
Ruxolitinib—CAMK1D—cerebellum—Alzheimer's disease	0.000566	0.00443	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—Alzheimer's disease	0.000564	0.00442	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—Alzheimer's disease	0.000563	0.00441	CbGeAlD
Ruxolitinib—Infection—Memantine—Alzheimer's disease	0.000562	0.00523	CcSEcCtD
Ruxolitinib—MARK2—brain—Alzheimer's disease	0.000557	0.00437	CbGeAlD
Ruxolitinib—STK16—central nervous system—Alzheimer's disease	0.000557	0.00436	CbGeAlD
Ruxolitinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000555	0.00516	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000554	0.00515	CcSEcCtD
Ruxolitinib—HIPK2—central nervous system—Alzheimer's disease	0.000554	0.00434	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—Alzheimer's disease	0.000553	0.00433	CbGeAlD
Ruxolitinib—DAPK3—nervous system—Alzheimer's disease	0.000553	0.00433	CbGeAlD
Ruxolitinib—TAOK3—telencephalon—Alzheimer's disease	0.000552	0.00432	CbGeAlD
Ruxolitinib—Infection—Rivastigmine—Alzheimer's disease	0.00055	0.00511	CcSEcCtD
Ruxolitinib—Skin disorder—Memantine—Alzheimer's disease	0.00055	0.00511	CcSEcCtD
Ruxolitinib—CLK2—nervous system—Alzheimer's disease	0.000548	0.00429	CbGeAlD
Ruxolitinib—STK16—cerebellum—Alzheimer's disease	0.000544	0.00426	CbGeAlD
Ruxolitinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000543	0.00505	CcSEcCtD
Ruxolitinib—MAP3K19—central nervous system—Alzheimer's disease	0.000543	0.00425	CbGeAlD
Ruxolitinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000542	0.00504	CcSEcCtD
Ruxolitinib—HIPK2—cerebellum—Alzheimer's disease	0.000541	0.00424	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000538	0.005	CcSEcCtD
Ruxolitinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000538	0.005	CcSEcCtD
Ruxolitinib—Fatigue—Donepezil—Alzheimer's disease	0.000537	0.005	CcSEcCtD
Ruxolitinib—DAPK3—central nervous system—Alzheimer's disease	0.000532	0.00417	CbGeAlD
Ruxolitinib—Dizziness—Galantamine—Alzheimer's disease	0.000532	0.00494	CcSEcCtD
Ruxolitinib—ROCK1—nervous system—Alzheimer's disease	0.000531	0.00416	CbGeAlD
Ruxolitinib—CLK2—central nervous system—Alzheimer's disease	0.000527	0.00413	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—Alzheimer's disease	0.00052	0.00408	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—Alzheimer's disease	0.000518	0.00406	CbGeAlD
Ruxolitinib—TAOK2—brain—Alzheimer's disease	0.000516	0.00404	CbGeAlD
Ruxolitinib—BMPR2—nervous system—Alzheimer's disease	0.000515	0.00404	CbGeAlD
Ruxolitinib—CLK2—cerebellum—Alzheimer's disease	0.000515	0.00404	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—Alzheimer's disease	0.000511	0.004	CbGeAlD
Ruxolitinib—Headache—Galantamine—Alzheimer's disease	0.000504	0.00468	CcSEcCtD
Ruxolitinib—DYRK1A—central nervous system—Alzheimer's disease	0.000498	0.0039	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—Alzheimer's disease	0.000496	0.00389	CbGeAlD
Ruxolitinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000493	0.00458	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000489	0.00454	CcSEcCtD
Ruxolitinib—Fatigue—Memantine—Alzheimer's disease	0.000488	0.00454	CcSEcCtD
Ruxolitinib—DYRK1A—cerebellum—Alzheimer's disease	0.000487	0.00382	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—Alzheimer's disease	0.000485	0.0038	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000478	0.00444	CcSEcCtD
Ruxolitinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000477	0.00444	CcSEcCtD
Ruxolitinib—JAK3—brain—Alzheimer's disease	0.000474	0.00371	CbGeAlD
Ruxolitinib—JAK1—brain—Alzheimer's disease	0.000471	0.00369	CbGeAlD
Ruxolitinib—DCLK1—brain—Alzheimer's disease	0.000471	0.00369	CbGeAlD
Ruxolitinib—PLK4—brain—Alzheimer's disease	0.000468	0.00367	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—Alzheimer's disease	0.000464	0.00363	CbGeAlD
Ruxolitinib—BMP2K—nervous system—Alzheimer's disease	0.000461	0.00361	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—Alzheimer's disease	0.000461	0.00361	CbGeAlD
Ruxolitinib—CAMK1D—brain—Alzheimer's disease	0.00046	0.0036	CbGeAlD
Ruxolitinib—LRRK2—nervous system—Alzheimer's disease	0.000457	0.00358	CbGeAlD
Ruxolitinib—PHKG2—brain—Alzheimer's disease	0.000457	0.00358	CbGeAlD
Ruxolitinib—DAPK2—brain—Alzheimer's disease	0.000449	0.00352	CbGeAlD
Ruxolitinib—Body temperature increased—Memantine—Alzheimer's disease	0.000447	0.00416	CcSEcCtD
Ruxolitinib—Asthenia—Donepezil—Alzheimer's disease	0.000447	0.00416	CcSEcCtD
Ruxolitinib—BMP2K—central nervous system—Alzheimer's disease	0.000444	0.00348	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—Alzheimer's disease	0.000444	0.00348	CbGeAlD
Ruxolitinib—STK16—brain—Alzheimer's disease	0.000442	0.00346	CbGeAlD
Ruxolitinib—Pruritus—Donepezil—Alzheimer's disease	0.000441	0.0041	CcSEcCtD
Ruxolitinib—LRRK2—central nervous system—Alzheimer's disease	0.00044	0.00345	CbGeAlD
Ruxolitinib—HIPK2—brain—Alzheimer's disease	0.00044	0.00345	CbGeAlD
Ruxolitinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000438	0.00407	CcSEcCtD
Ruxolitinib—CAMK2G—cerebellum—Alzheimer's disease	0.000434	0.0034	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—Alzheimer's disease	0.000434	0.0034	CbGeAlD
Ruxolitinib—MAP3K19—brain—Alzheimer's disease	0.000431	0.00338	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—Alzheimer's disease	0.00043	0.00337	CbGeAlD
Ruxolitinib—DAPK3—brain—Alzheimer's disease	0.000422	0.00331	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—Alzheimer's disease	0.000419	0.00328	CbGeAlD
Ruxolitinib—CLK2—brain—Alzheimer's disease	0.000419	0.00328	CbGeAlD
Ruxolitinib—Dizziness—Donepezil—Alzheimer's disease	0.000412	0.00383	CcSEcCtD
Ruxolitinib—TYK2—nervous system—Alzheimer's disease	0.000407	0.00319	CbGeAlD
Ruxolitinib—Asthenia—Memantine—Alzheimer's disease	0.000406	0.00377	CcSEcCtD
Ruxolitinib—ROCK1—brain—Alzheimer's disease	0.000406	0.00318	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—Alzheimer's disease	0.000403	0.00316	CbGeAlD
Ruxolitinib—MKNK2—nervous system—Alzheimer's disease	0.000402	0.00315	CbGeAlD
Ruxolitinib—Pruritus—Memantine—Alzheimer's disease	0.0004	0.00372	CcSEcCtD
Ruxolitinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000397	0.00369	CcSEcCtD
Ruxolitinib—DYRK1A—brain—Alzheimer's disease	0.000396	0.0031	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—Alzheimer's disease	0.000394	0.00309	CbGeAlD
Ruxolitinib—BMPR2—brain—Alzheimer's disease	0.000394	0.00309	CbGeAlD
Ruxolitinib—TYK2—central nervous system—Alzheimer's disease	0.000392	0.00307	CbGeAlD
Ruxolitinib—RET—nervous system—Alzheimer's disease	0.000392	0.00307	CbGeAlD
Ruxolitinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000392	0.00364	CcSEcCtD
Ruxolitinib—Headache—Donepezil—Alzheimer's disease	0.00039	0.00363	CcSEcCtD
Ruxolitinib—MAP3K7—cerebellum—Alzheimer's disease	0.00039	0.00306	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—Alzheimer's disease	0.000387	0.00303	CbGeAlD
Ruxolitinib—TYK2—cerebellum—Alzheimer's disease	0.000383	0.003	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—Alzheimer's disease	0.000378	0.00297	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—Alzheimer's disease	0.000378	0.00297	CbGeAlD
Ruxolitinib—RET—central nervous system—Alzheimer's disease	0.000378	0.00296	CbGeAlD
Ruxolitinib—NUAK2—brain—Alzheimer's disease	0.000377	0.00295	CbGeAlD
Ruxolitinib—Dizziness—Memantine—Alzheimer's disease	0.000374	0.00348	CcSEcCtD
Ruxolitinib—JAK2—nervous system—Alzheimer's disease	0.000371	0.0029	CbGeAlD
Ruxolitinib—RET—cerebellum—Alzheimer's disease	0.000369	0.00289	CbGeAlD
Ruxolitinib—Dizziness—Rivastigmine—Alzheimer's disease	0.000366	0.0034	CcSEcCtD
Ruxolitinib—MAP3K3—nervous system—Alzheimer's disease	0.000357	0.0028	CbGeAlD
Ruxolitinib—JAK2—central nervous system—Alzheimer's disease	0.000357	0.0028	CbGeAlD
Ruxolitinib—Headache—Memantine—Alzheimer's disease	0.000355	0.0033	CcSEcCtD
Ruxolitinib—CAMK2G—brain—Alzheimer's disease	0.000353	0.00276	CbGeAlD
Ruxolitinib—BMP2K—brain—Alzheimer's disease	0.000353	0.00276	CbGeAlD
Ruxolitinib—LRRK2—brain—Alzheimer's disease	0.000349	0.00274	CbGeAlD
Ruxolitinib—JAK2—cerebellum—Alzheimer's disease	0.000349	0.00273	CbGeAlD
Ruxolitinib—Headache—Rivastigmine—Alzheimer's disease	0.000347	0.00322	CcSEcCtD
Ruxolitinib—MAP3K3—central nervous system—Alzheimer's disease	0.000344	0.0027	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—Alzheimer's disease	0.000336	0.00263	CbGeAlD
Ruxolitinib—TAOK3—nervous system—Alzheimer's disease	0.000326	0.00255	CbGeAlD
Ruxolitinib—MAP3K2—brain—Alzheimer's disease	0.00032	0.00251	CbGeAlD
Ruxolitinib—MAP3K7—brain—Alzheimer's disease	0.000317	0.00249	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—Alzheimer's disease	0.000314	0.00246	CbGeAlD
Ruxolitinib—TYK2—brain—Alzheimer's disease	0.000311	0.00244	CbGeAlD
Ruxolitinib—MKNK2—brain—Alzheimer's disease	0.000307	0.00241	CbGeAlD
Ruxolitinib—IRAK1—brain—Alzheimer's disease	0.000307	0.00241	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—Alzheimer's disease	0.000307	0.0024	CbGeAlD
Ruxolitinib—RET—brain—Alzheimer's disease	0.0003	0.00235	CbGeAlD
Ruxolitinib—JAK2—brain—Alzheimer's disease	0.000283	0.00222	CbGeAlD
Ruxolitinib—MAP3K3—brain—Alzheimer's disease	0.000273	0.00214	CbGeAlD
Ruxolitinib—TAOK3—brain—Alzheimer's disease	0.000249	0.00195	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—Alzheimer's disease	9.9e-05	0.000775	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—Alzheimer's disease	9.53e-05	0.000747	CbGeAlD
Ruxolitinib—MAP3K7—Signaling Pathways—PRKCG—Alzheimer's disease	3.12e-06	1.46e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—Alzheimer's disease	3.11e-06	1.46e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—Alzheimer's disease	3.11e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IGF1—Alzheimer's disease	3.11e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—BCL2—Alzheimer's disease	3.1e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NGFR—Alzheimer's disease	3.08e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—Alzheimer's disease	3.07e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—Alzheimer's disease	3.07e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CREB1—Alzheimer's disease	3.06e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IGF1—Alzheimer's disease	3.05e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—Alzheimer's disease	3.05e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.05e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NGF—Alzheimer's disease	3.04e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AKT1—Alzheimer's disease	3.04e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MAPK8—Alzheimer's disease	3.03e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—AKT1—Alzheimer's disease	3.02e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CALM1—Alzheimer's disease	3.01e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADAM10—Alzheimer's disease	3.01e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOE—Alzheimer's disease	3e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—BCL2—Alzheimer's disease	3e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—Alzheimer's disease	2.99e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—Alzheimer's disease	2.99e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—Alzheimer's disease	2.98e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—Alzheimer's disease	2.98e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CAV1—Alzheimer's disease	2.97e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—Alzheimer's disease	2.97e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—Alzheimer's disease	2.96e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—Alzheimer's disease	2.92e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.92e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—Alzheimer's disease	2.89e-06	1.35e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—AKT1—Alzheimer's disease	2.87e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CALM1—Alzheimer's disease	2.87e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOE—Alzheimer's disease	2.86e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—Alzheimer's disease	2.86e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—S100B—Alzheimer's disease	2.84e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—Alzheimer's disease	2.83e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CAV1—Alzheimer's disease	2.83e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—Alzheimer's disease	2.82e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—GSK3B—Alzheimer's disease	2.82e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—Alzheimer's disease	2.82e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.81e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.8e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—Alzheimer's disease	2.8e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—Alzheimer's disease	2.79e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CREB1—Alzheimer's disease	2.79e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CALM1—Alzheimer's disease	2.78e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CASP3—Alzheimer's disease	2.78e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOE—Alzheimer's disease	2.77e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—Alzheimer's disease	2.77e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOTCH1—Alzheimer's disease	2.77e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—Alzheimer's disease	2.77e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—Alzheimer's disease	2.76e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—Alzheimer's disease	2.76e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—AKT1—Alzheimer's disease	2.76e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—Alzheimer's disease	2.75e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CAV1—Alzheimer's disease	2.75e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AKT1—Alzheimer's disease	2.75e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—Alzheimer's disease	2.74e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—Alzheimer's disease	2.74e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ESR1—Alzheimer's disease	2.73e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—Alzheimer's disease	2.71e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.71e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF2—Alzheimer's disease	2.71e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CALM1—Alzheimer's disease	2.7e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—F2—Alzheimer's disease	2.7e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—Alzheimer's disease	2.69e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOE—Alzheimer's disease	2.69e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—Alzheimer's disease	2.67e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—Alzheimer's disease	2.67e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CAV1—Alzheimer's disease	2.67e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—Alzheimer's disease	2.66e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—Alzheimer's disease	2.65e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ESR1—Alzheimer's disease	2.65e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.64e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1R—Alzheimer's disease	2.62e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—F2—Alzheimer's disease	2.62e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—AKT1—Alzheimer's disease	2.61e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GSK3B—Alzheimer's disease	2.6e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—MAPK8—Alzheimer's disease	2.58e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CREB1—Alzheimer's disease	2.58e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ESR1—Alzheimer's disease	2.57e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—INS—Alzheimer's disease	2.57e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—Alzheimer's disease	2.56e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.56e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MAPK8—Alzheimer's disease	2.55e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AKT1—Alzheimer's disease	2.55e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—AKT1—Alzheimer's disease	2.55e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—F2—Alzheimer's disease	2.54e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—AKT1—Alzheimer's disease	2.54e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—Alzheimer's disease	2.53e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—AKT1—Alzheimer's disease	2.53e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—Alzheimer's disease	2.52e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—MAPK8—Alzheimer's disease	2.51e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LPL—Alzheimer's disease	2.51e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MEF2C—Alzheimer's disease	2.49e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOTCH1—Alzheimer's disease	2.48e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—GSK3B—Alzheimer's disease	2.47e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—AKT1—Alzheimer's disease	2.47e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—AKT1—Alzheimer's disease	2.46e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CREB1—Alzheimer's disease	2.46e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—INS—Alzheimer's disease	2.44e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRKCG—Alzheimer's disease	2.44e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—MAPK8—Alzheimer's disease	2.43e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.41e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—GSK3B—Alzheimer's disease	2.4e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—Alzheimer's disease	2.4e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CASP3—Alzheimer's disease	2.39e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CREB1—Alzheimer's disease	2.38e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NGF—Alzheimer's disease	2.38e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—Alzheimer's disease	2.37e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.37e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—INS—Alzheimer's disease	2.37e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—AKT1—Alzheimer's disease	2.36e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF1—Alzheimer's disease	2.36e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—Alzheimer's disease	2.36e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—Alzheimer's disease	2.36e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CASP3—Alzheimer's disease	2.35e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—BCL2—Alzheimer's disease	2.35e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—Alzheimer's disease	2.34e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—Alzheimer's disease	2.33e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—GSK3B—Alzheimer's disease	2.33e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—AKT1—Alzheimer's disease	2.33e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CREB1—Alzheimer's disease	2.31e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—Alzheimer's disease	2.31e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—INS—Alzheimer's disease	2.3e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF1—Alzheimer's disease	2.29e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—Alzheimer's disease	2.26e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—Alzheimer's disease	2.26e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—Alzheimer's disease	2.25e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF1—Alzheimer's disease	2.22e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MAPK8—Alzheimer's disease	2.2e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AKT1—Alzheimer's disease	2.19e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—AKT1—Alzheimer's disease	2.18e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—Alzheimer's disease	2.17e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—Alzheimer's disease	2.16e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MAPK8—Alzheimer's disease	2.16e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AKT1—Alzheimer's disease	2.15e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—Alzheimer's disease	2.14e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—AKT1—Alzheimer's disease	2.14e-06	1e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—Alzheimer's disease	2.11e-06	9.88e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALM1—Alzheimer's disease	2.11e-06	9.88e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—Alzheimer's disease	2.1e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—Alzheimer's disease	2.1e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—Alzheimer's disease	2.08e-06	9.75e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CAV1—Alzheimer's disease	2.08e-06	9.75e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—Alzheimer's disease	2.08e-06	9.73e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—Alzheimer's disease	2.07e-06	9.7e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—Alzheimer's disease	2.06e-06	9.63e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—Alzheimer's disease	2.03e-06	9.49e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—Alzheimer's disease	2.02e-06	9.44e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ESR1—Alzheimer's disease	2.01e-06	9.39e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—Alzheimer's disease	2e-06	9.38e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—AKT1—Alzheimer's disease	2e-06	9.37e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—Alzheimer's disease	2e-06	9.34e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—F2—Alzheimer's disease	1.98e-06	9.28e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—Alzheimer's disease	1.96e-06	9.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.94e-06	9.08e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—Alzheimer's disease	1.93e-06	9.04e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—AKT1—Alzheimer's disease	1.92e-06	9e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MAPK8—Alzheimer's disease	1.9e-06	8.9e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.86e-06	8.71e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—AKT1—Alzheimer's disease	1.85e-06	8.65e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.83e-06	8.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GSK3B—Alzheimer's disease	1.82e-06	8.52e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CASP3—Alzheimer's disease	1.82e-06	8.51e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CREB1—Alzheimer's disease	1.81e-06	8.45e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—INS—Alzheimer's disease	1.8e-06	8.41e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AKT1—Alzheimer's disease	1.78e-06	8.34e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—Alzheimer's disease	1.78e-06	8.34e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—Alzheimer's disease	1.77e-06	8.27e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CASP3—Alzheimer's disease	1.76e-06	8.26e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—Alzheimer's disease	1.75e-06	8.21e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.75e-06	8.19e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.75e-06	8.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—Alzheimer's disease	1.74e-06	8.13e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CASP3—Alzheimer's disease	1.71e-06	8.01e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.68e-06	7.85e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-06	7.82e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—Alzheimer's disease	1.65e-06	7.72e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—Alzheimer's disease	1.63e-06	7.63e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAPK8—Alzheimer's disease	1.62e-06	7.59e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	7.57e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.61e-06	7.55e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—Alzheimer's disease	1.6e-06	7.5e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	7.37e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	7.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.56e-06	7.3e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—Alzheimer's disease	1.55e-06	7.27e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.54e-06	7.22e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—Alzheimer's disease	1.53e-06	7.17e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AKT1—Alzheimer's disease	1.52e-06	7.12e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	7.05e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	7.04e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	7.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—Alzheimer's disease	1.49e-06	6.96e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—Alzheimer's disease	1.48e-06	6.92e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AKT1—Alzheimer's disease	1.48e-06	6.92e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	6.8e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AKT1—Alzheimer's disease	1.43e-06	6.71e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	6.63e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—Alzheimer's disease	1.4e-06	6.57e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	6.46e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	6.43e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AKT1—Alzheimer's disease	1.36e-06	6.39e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.36e-06	6.35e-06	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-06	6.32e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.34e-06	6.27e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	6.26e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	6.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	6.22e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AKT1—Alzheimer's disease	1.29e-06	6.06e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	5.96e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.27e-06	5.95e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.27e-06	5.95e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.25e-06	5.83e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	5.75e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	5.74e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—Alzheimer's disease	1.21e-06	5.68e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.18e-06	5.53e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	5.45e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—Alzheimer's disease	1.13e-06	5.31e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	5.3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—Alzheimer's disease	1.12e-06	5.25e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AKT1—Alzheimer's disease	1.12e-06	5.24e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.11e-06	5.22e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	5.14e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.08e-06	5.06e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	4.99e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	4.87e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	4.85e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AKT1—Alzheimer's disease	1.03e-06	4.84e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—Alzheimer's disease	1e-06	4.7e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AKT1—Alzheimer's disease	9.84e-07	4.61e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AKT1—Alzheimer's disease	9.55e-07	4.47e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	9.31e-07	4.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.27e-07	4.34e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AKT1—Alzheimer's disease	9.27e-07	4.34e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—Alzheimer's disease	8.57e-07	4.01e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	8.48e-07	3.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—Alzheimer's disease	7.85e-07	3.67e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.63e-07	3.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKT1—Alzheimer's disease	7.24e-07	3.39e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.13e-07	3.34e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.11e-07	3.33e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.04e-07	3.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.19e-07	2.9e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INS—Alzheimer's disease	6.07e-07	2.84e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.32e-07	2.49e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.87e-07	2.28e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.45e-07	1.15e-06	CbGpPWpGaD
